134 related articles for article (PubMed ID: 2807601)
21. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
22. Effects of double filtration plasmapheresis on nocturnal respiratory function in myasthenic patients.
Yeh JH; Lin CM; Chen WH; Chiu HC
Artif Organs; 2013 Dec; 37(12):1076-9. PubMed ID: 23865547
[TBL] [Abstract][Full Text] [Related]
23. Double Filtration Plasmapheresis (DFPP) in Severe Hypertriglyceridemia Patients - a Pilot Study.
Lei Y; Liang Y; Zhang X; Tang C; Zheng Z; Wang X
Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975533
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulation Effect and Safety Observation of Regional Citrate Anticoagulation for Double-Filtration Plasmapheresis in Critical Patients.
Peng X; Xie X; Yin J; Yu S; Zhang C; Zhao S
Blood Purif; 2020; 49(5):542-549. PubMed ID: 32191939
[TBL] [Abstract][Full Text] [Related]
25. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
Hellebrekers LJ; Slappendel RJ; van den Brom WE
Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
[TBL] [Abstract][Full Text] [Related]
26. The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
Yoshimura H; Yoshikawa Y; Noguchi Y; Totani T; Kusuta R; Shimazu K; Tanaka A; Komura K
J Clin Apher; 2023 Aug; 38(4):362-367. PubMed ID: 36367055
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: A retrospective observational study.
Xu X; Gao C; Han P
J Clin Apher; 2023 Aug; 38(4):368-375. PubMed ID: 36420568
[TBL] [Abstract][Full Text] [Related]
28. A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C.
Cao H; Wen P; Ye H; Sun Z; Shen X; Wu X; Dai C; Yang J
PLoS One; 2013; 8(12):e82524. PubMed ID: 24358197
[TBL] [Abstract][Full Text] [Related]
29. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
Seishima M; Shibuya Y; Kato G; Aoki T
Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
[TBL] [Abstract][Full Text] [Related]
30. Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
Kim JY; Park JS; Park JC; Kim ME; Nahm DH
Ther Apher Dial; 2013 Dec; 17(6):631-7. PubMed ID: 24330559
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
32. Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
Bozkirli DE; Kozanoglu I; Bozkirli E; Yucel E
J Clin Apher; 2013 Dec; 28(6):422-5. PubMed ID: 23908096
[TBL] [Abstract][Full Text] [Related]
33. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
[TBL] [Abstract][Full Text] [Related]
34. Continuous monitoring of blood volume in double filtration plasmapheresis.
Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
[TBL] [Abstract][Full Text] [Related]
35. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
37. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
[TBL] [Abstract][Full Text] [Related]
38. Influence of different heparin concentrations on the results of in vitro investigations in plasmaseparation technology using capillary membrane filters.
Unger JK; Haltern C; Dohmen B; Rossaint R
Artif Organs; 2003 Jul; 27(7):649-57. PubMed ID: 12823420
[TBL] [Abstract][Full Text] [Related]
39. Effect of heparin on activated partial thromboplastin time in patients undergoing gynecologic or obstetric surgery.
Watanabe T; Minakami H; Sakata Y; Obara H; Wada T; Onagawa T; Sato I
Gynecol Obstet Invest; 2001; 51(3):178-83. PubMed ID: 11306905
[TBL] [Abstract][Full Text] [Related]
40. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
